Egami, F. and Oshima, Y. Ed.: Biochemistry and Medicine of Mucopolysaccharides. Univ. of Tokyo, 1962. p. 1.
2.
Meyer, K., Davidson, E., Linker, A. and Hoffman, P.: Biochim. Biophys. Acta.21: 506, 1956.
3.
Meyer, K.: Nature and Function of Mucopolysaccharides of Connective Tissue. In: Molecular Biology, Ed. Nachmansohn, D. p. 69. Academic Press , New York1960.
4.
Murata, K.: The Effect of Sulfated Mono and Polysaccharides on Experimental Hyperlipemia and Atherosclerosis in Rabbits. Japan Heart J.2: 198-209, 1961.
5.
Morrison, L.M. , Quilligan, J.J. Jr., Murata, K., Schjeide, O.A., Freeman, L. and Ershoff, B.H.: Treatment of Atherosclerosis With Acid Mucopolysaccharides. Exp. Med. and Surg.25#1: 61-71, March 1967.
6.
Gillman, T., Hathorn, M. and Penn, J.: Micro-Anatomy and Reactions to Injury of Vascular Elastic Membranes and Associated Polysaccharides in Connective Tissue. Blackwell Scientific PublicationsOxford, England pp. 3-23, 1957.
7.
Bazin, S. and Delaunay, A.: Biochimie de l'Inflammation IV. Ann. Inst. Pasteur105: 624, 1963.
8.
Bazin, S. and Delaunay, A.: Biochimie de l'Inflammation V. Ann. Inst. Pasteur106: 329, 1964.
9.
Delaunay, A. and Bazin, S.: Mucopolysaccharides, Collagen and Nonfibrillar Proteins in Inflammation. Intern. Rev. Connective Tissue Res.2: 301, 1964.
10.
Morrison, L.M. , Murata, K., Quilligan, J.J. Jr., Schjeide , O.A. and Freeman, L.: Prevention of Atherosclerosis in Sub-human Primates By Chondroitin Sulfate A. Circulation Res.19: 358-63, 1966.
11.
Morrison, L.M. , Rucker, P.G. and Ershoff, B.H.: Prolongation of Thrombus-Formation Time in Rabbits Given Chondroitin Sulfate A. J. Atherscler. Res.8: 319-327, 1968.
12.
Morrison, L.M. , Schjeide, O.A., Quilligan, J.J. Jr., Freeman, L. and Murata, K.: Metabolic Parameters in the Growth-Stimulating Effect of Chondroitin Sulfate A in Tissue Cultures. Proc. Soc. Exptl. Bio. and Med.119: 618-622, 1965.
13.
Schiller, S. : The Isolation of Chondroitin Sulfuric Acid From Normal Human Plasma. Biochim. Biophys. Acta28: 413. 1958.
14.
Berenson, G.S. , Dalferes, E.R., Robin, R. and Strong, J.P.: Mucopolysaccharides and Atherosclerosis . In: "Evolution of the Atherosclerotic Plaque. Ed. R. J. Jones.Univ. of Chicago Press pp. 144-146, 1963.
15.
Kirk, J.E. and Dyrbye, M.O.: Mucopolysaccharides of Human Arterial Tissue. II. Analysis of Total Isolated Mucopolysaccharide Material. J. Geront.12: 23-31, 1957.
16.
Dyrbye, M.O.: Aging of Human Arterial Tissue. Biochemical Studies of the Acid Mucopolysaccharides . Munksgaard Co., Copenhagen, 1959.
17.
Meyer, K.: Mucopolysaccharide Composition of the Vessel Wall. In: Small Blood Vessel Involvement in Diabetes Mellitus, p. 193. Ed. Siperstein, M. D. et al. American Institute of Biological Sciences, Washington, D.C.1964.
18.
Morrison, L.M. , Schjeide, O.A., Quilligan, J.J., Jr., Freeman , L. and Holeman, R.: Effects of Acid Mucopolysaccharides on Growth Rates and Constituent Lipids of Tissue Cultures . Proc. Soc. Exptl. Biol. and Med.113: 362-366, 1963.
19.
Morrison, L. M., Murata, K., Schjeide, O. A. and Quilligan, J. J., Jr: Data to be published.
20.
Morrison, L.M. , Murata, K., Quilligan J.J. Jr., Schjeide , O.A. and Freeman, L.: Growth Stimulating Effects of Acid Mucopolysaccharides. Proc. Soc. Exptl. Bio. and Med.118: 770-772, 1965.
21.
Morrison, L.M. , Bernick, S., Alfin-Slater, R.B.Patek, P.R. and Ershoff B.H.: Inhibition of Coronary Atherosclerosis in the X-Irradiated, Cholesterol Fed Rat by Chondroitin Sulfate A. Proc. Soc. Exptl. Bio. and Med.123: 904-911. 1966.
22.
Robbins, R.C. , Morrison, L.M. and Simpson, C.F.: Effect of Chondroitin Sulfate A and Flavonoids on Hypervitaminosis D in Rats. Proc. Soc. Exptl. Bio. and Med.131: 719-722, 1969.
23.
Morrison, L.M., Bajwa, G.S. and Ershoff, B.H.: Preventive Effects of Chondroitin Sulfate A Against Experimentally Induced Aortic and Coronary Atherosclerosis in the Rat. Circulation, Vols. 39 and 40. Supplement III, #4. p. 18, Oct. 1969.
24.
Kurita, H. : Uber den Einfluss des Chondroitin-sulfates auf die Experimentalle Atherosklerose in Kaninchen. Medical J. Shinahu Univ.1: 23, 1955.
25.
Same as #1. pp. 259-272.
26.
Morrison, L.M., Bernick, S. and Ershoff, B.H.: Regression of Coronary Atherosclerosis in Rats Fed Chondroitin Sulfate A. Circulation, Vols. 35 and 36. Supplement II. p. 28, Oct. 1967.
27.
Morrison, L. M., Bajwa, G. S. and Ershoff, B. H.: To be published.
28.
Morrison, L.M., Bajwa, G.S. and Ershoff, B.H.: Prolongation of the Plasma Thrombus Formation Time of Dogs Administered Chondroitin Sulfates A and C. Exper. Med. and Surg. In press.
29.
Morrison, L.M. , Rucker, P.G. and Dunn, O.J.: Prolongation of Thrombus Formation Time in Angina Pectoris By Chondroitin Sulfate A. Circulation, Vols. 35 and 36, Supplement II, Oct. 1967.
30.
Srinivasan, S.: Personal communication.
31.
Morrison, L.M., Bajwa, G.S. and Ershoff, B.H.: Increased Collateral Circulation Following Oral Administration of Chondroitin Sulfate A in Rats Fed an Atherogenic Diet. Abstract. Submitted to Council on Arteriosclerosis, American Heart Association Meetings, Nov. 10-11, 1970.
32.
Morrison, L.M. , Bajwa, G.S. and Ershoff, B.H.: Therapeutic Effects of Orally Administered Chondroitin Sulfate A in the Prevention of Aortic and Coronary Atherosclerosis in Rats. Abstract. The Gerontologist10#3, Part II: 22, Autumn, 1970.
33.
Wasteson, A.: A Method for the Determination of Molecular Weight Disperson in Chondroitin Sulfate on a Microgram Level. Biochim. Biophys. Acta.177: 152-154, 1969.
34.
Vital Statistics for the United States 1967. Vol. 2, Mortality Part A, pp. 1-89. Published 1969.